These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 7066891)
1. Toxicity and anticancer activity of a new triazine antifolate (NSC 127755). Corbett TH; Leopold WR; Dykes DJ; Roberts BJ; Griswold DP; Schabel FM Cancer Res; 1982 May; 42(5):1707-15. PubMed ID: 7066891 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of antitumor activity of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine in murine tumors. Furusawa S; Mian AM Cancer Treat Rep; 1987 May; 71(5):441-6. PubMed ID: 3567967 [TBL] [Abstract][Full Text] [Related]
4. Augmentation of the therapeutic activity of lometrexol -(6-R)5,10-dideazatetrahydrofolate- by oral folic acid. Alati T; Worzalla JF; Shih C; Bewley JR; Lewis S; Moran RG; Grindey GB Cancer Res; 1996 May; 56(10):2331-5. PubMed ID: 8625328 [TBL] [Abstract][Full Text] [Related]
5. Flavone acetic acid: a novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice. Plowman J; Narayanan VL; Dykes D; Szarvasi E; Briet P; Yoder OC; Paull KD Cancer Treat Rep; 1986 May; 70(5):631-5. PubMed ID: 3708611 [TBL] [Abstract][Full Text] [Related]
6. MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinoma. Teicher BA; Alvarez E; Liu P; Lu K; Menon K; Dempsey J; Schultz RM Semin Oncol; 1999 Apr; 26(2 Suppl 6):55-62. PubMed ID: 10598556 [TBL] [Abstract][Full Text] [Related]
7. Preclinical antitumor efficacy of the polyamine analogue N1, N11-diethylnorspermine administered by multiple injection or continuous infusion. Bernacki RJ; Oberman EJ; Seweryniak KE; Atwood A; Bergeron RJ; Porter CW Clin Cancer Res; 1995 Aug; 1(8):847-57. PubMed ID: 9816054 [TBL] [Abstract][Full Text] [Related]
8. Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo. O'Dwyer PJ; Moyer JD; Suffness M; Harrison SD; Cysyk R; Hamilton TC; Plowman J Cancer Res; 1994 Feb; 54(3):724-9. PubMed ID: 8306334 [TBL] [Abstract][Full Text] [Related]
9. Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. van der Wilt CL; Backus HH; Smid K; Comijn L; Veerman G; Wouters D; Voorn DA; Priest DG; Bunni MA; Mitchell F; Jackman AL; Jansen G; Peters GJ Cancer Res; 2001 May; 61(9):3675-81. PubMed ID: 11325838 [TBL] [Abstract][Full Text] [Related]
10. [Combined drug therapy in transplanted colonic mice tumors]. Double JA; Cifuentes de Castro L; Lee PW Rev Clin Esp; 1979 Dec; 155(5):335-8. PubMed ID: 545477 [No Abstract] [Full Text] [Related]
11. Chemotherapy of transplantable adenocarcinomas of the colon in mice. II. Development and characterization of an ascitic line. Double JA; de Castro LC Cancer Treat Rep; 1978 Jan; 62(1):85-90. PubMed ID: 626999 [No Abstract] [Full Text] [Related]
12. [Antitumor activity and pharmacological properties of furizil]. Stukov AN; Kraĭz BO; Aleksandrov VA; Ivin BA; Filov VA Vopr Onkol; 1985; 31(5):52-4. PubMed ID: 4013130 [TBL] [Abstract][Full Text] [Related]
13. Antimetastatic and antitumor effects of 2,4-diamino-6-(pyridine-4-yl)-1,3,5-triazine (4PyDAT) on the high lung metastatic colon 26 tumor in mice. Maeda M; Ligo M; Tsuda H; Fujita H; Yonemura Y; Nakagawa K; Endo Y; Sasaki T Anticancer Drug Des; 2000 Jun; 15(3):217-23. PubMed ID: 11049089 [TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of imidazothioxanthones in murine and human tumor models in vitro and in vivo. Varvaresou A; Iakovou K; Gikas E; Fichtner I; Fiebig HH; Kelland LR; Double JA; Bibby MC; Hendriks HR Anticancer Res; 2004; 24(2B):907-19. PubMed ID: 15161044 [TBL] [Abstract][Full Text] [Related]
15. Response of transplantable tumors of mice to anthracenedione derivatives alone and in combination with clinically useful agents. Corbett TH; Roberts BJ; Trader MW; Laster WR; Griswold DP; Schabel FM Cancer Treat Rep; 1982 May; 66(5):1187-200. PubMed ID: 7083221 [TBL] [Abstract][Full Text] [Related]
16. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines. Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968 [TBL] [Abstract][Full Text] [Related]
17. BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy. Lee FY; Borzilleri R; Fairchild CR; Kim SH; Long BH; Reventos-Suarez C; Vite GD; Rose WC; Kramer RA Clin Cancer Res; 2001 May; 7(5):1429-37. PubMed ID: 11350914 [TBL] [Abstract][Full Text] [Related]
18. Experimental antitumor activity and toxicity of the selected triazolo- and imidazoacridinones. Kuśnierczyk H; Chołody WM; Paradziej-Lukowicz J; Radzikowski C; Konopa J Arch Immunol Ther Exp (Warsz); 1994; 42(5-6):415-23. PubMed ID: 8572901 [TBL] [Abstract][Full Text] [Related]
19. Potent antitumor effect of 1-(2-deoxy-2-fluoro-4-thio-beta-D-arabinofuranosyl)cytosine on peritoneal dissemination models of gastrointestinal cancers. Miura S; Endo Y; Yoshimura Y; Endo M; Yonemura Y; Sasaki T Oncol Rep; 2002; 9(6):1319-22. PubMed ID: 12375041 [TBL] [Abstract][Full Text] [Related]
20. Preclinical antitumor activity of bizelesin in mice. Carter CA; Waud WR; Li LH; DeKoning TF; McGovren JP; Plowman J Clin Cancer Res; 1996 Jul; 2(7):1143-9. PubMed ID: 9816280 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]